IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
28.13
-0.19 (-0.67%)
May 11, 2026, 4:00 PM EDT - Market closed

IDEAYA Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,4723,0352,2232,314876911
Market Cap Growth
48.60%36.52%-3.93%164.27%-3.87%120.28%
Enterprise Value
1,5272,4231,5661,790512.45667.63
Last Close Price
28.1334.5725.7035.5818.1723.64
PE Ratio
--27.01-7.65-18.15-12.80-16.77
PS Ratio
10.9713.88317.5998.9617.1932.60
PB Ratio
2.642.972.103.732.513.02
P/TBV Ratio
2.672.991.983.302.152.76
P/FCF Ratio
--41.31-8.84-19.68-9.66-15.59
P/OCF Ratio
--42.69-8.98-20.08-10.04-16.33
EV/Sales Ratio
6.7811.08223.6776.5510.0623.89
EV/EBITDA Ratio
--15.66-4.85-13.73-8.69-14.13
EV/EBIT Ratio
--15.21-4.79-13.32-8.20-13.28
EV/FCF Ratio
--32.99-6.23-15.22-5.66-11.43
Debt / Equity Ratio
0.030.030.020.000.000.01
Debt / EBITDA Ratio
-0.16-0.18-0.06-0.02-0.06-0.11
Debt / FCF Ratio
-0.32-0.38-0.08-0.02-0.04-0.09
Net Debt / Equity Ratio
-0.69-0.60-0.62-0.84-1.03-0.80
Net Debt / EBITDA Ratio
3.593.952.034.006.135.12
Net Debt / FCF Ratio
7.318.322.614.443.994.14
Asset Turnover
0.210.200.010.050.130.08
Quick Ratio
10.3510.8714.6819.3811.515.49
Current Ratio
10.7411.3414.9719.6511.685.56
Return on Equity (ROE)
-14.29%-10.92%-32.67%-23.28%-18.02%-19.91%
Return on Assets (ROA)
-17.15%-14.27%-36.88%-25.92%-16.25%-14.79%
Return on Invested Capital (ROIC)
-51.96%-39.17%-130.57%-266.96%-102.45%-80.19%
Return on Capital Employed (ROCE)
-18.20%-14.97%-38.46%-27.48%-18.05%-16.87%
Earnings Yield
-5.67%-3.70%-13.07%-5.51%-7.82%-5.96%
FCF Yield
-3.56%-2.42%-11.31%-5.08%-10.35%-6.41%
Buyback Yield / Dilution
-4.21%-8.33%-42.00%-38.79%-17.57%-42.60%
Total Shareholder Return
-4.21%-8.33%-42.00%-38.79%-17.57%-42.60%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q